H. R. Hygiene Products Limited is a manufacturer of personal hygiene products with a dual-channel distribution strategy across the Indian market. The company’s core value proposition centres on providing affordable, high-quality, and scientifically validated hygiene solutions. Its underlying business model incorporates manufacturing and trading activities, distributing products through General Trade (GT) offline networks via dealers, as well as maintaining a robust B2B and B2C digital presence across major e-commerce platforms like Meesho, Amazon, Flipkart, and JioMart. Additionally, the company leverages its manufacturing capabilities to offer white-labeling services for other customers. The company’s product portfolio caters to a highly diversified demographic, encompassing infants, young women, and the elderly. Its offerings are organized under distinct proprietary brands: 'Femiss' for economy sanitary napkins, 'Womanica' for premium, high-absorbency feminine care, 'ElderFit' addressing the adult incontinence market, and 'Bloom Baby' for infant care. Geographically, the company services over 227 customers across 28 states and 8 union territories. Its market presence is particularly dominant in Western India, with its home state of Gujarat contributing 77.02% of total operational revenues in FY26, supported by an expansive network of 25 Consignment Sale Agents (CSAs) and approximately 202 distributors. The company operates from a state-of-the-art, fully automated manufacturing facility located in Lothada, Rajkot (Gujarat), sprawling across 32,780.88 sq. ft. This facility integrates advanced technological systems sourced from China, enabling end-to-end automation from raw material handling to packaging. As of FY26, the company operates two major production lines for sanitary pads: Machine-1 with an installed capacity of 12 Crore pieces per annum operating at a 92.75% capacity utilization rate, and Machine-2 with an 8 Crore pieces per annum capacity operating at an 87.75% utilization rate. The aggregate installed capacity stands at 20 Crore pieces annually. Operationally, H.R. Hygiene prioritizes stringent quality control and sustainable manufacturing excellence. The Rajkot facility complies with global health and hygiene standards, holding key accreditations including ISO 9001:2015, WHO-GMP, FDA, CE, and mandatory BIS product certifications. The company maintains an in-house laboratory monitored by a dedicated quality assurance team of 5 personnel to conduct rigorous multi-stage testing of raw materials and finished goods. Furthermore, its operational strategy emphasizes lean manufacturing, real-time inventory tracking, and supply chain optimization to minimize wastage, reduce lead times, and adapt to consumer demand fluctuations effectively. As per financial performance, H. R. Hygiene Products Limited has posted total income / net profits of Rs 85.33 Cr / Rs 4.66 Cr (FY24), Rs 115.15 Cr / Rs 9.08 Cr (FY25) and Rs 131.90 Cr / Rs 11.41 Cr (FY26). So as per previous financials data, the company has shown strong top-line and bottom-line growth on paper, though this is heavily contradicted by severe working capital stress, ballooning trade receivables (representing ~80% of FY26 revenue), and consistently negligible or negative operating cash flows. Company has an average EPS of Rs 5.43 and average RoNW of 36.27% for the last three fiscals. Based on the pre-issue book value, the issue is priced at a Pre-Issue P/BV of 3.70x as per NAV of Rs 23.80 as on 31.03.26. Factoring in the fresh issue proceeds, the Post-Issue P/BV stands at 2.34x. If we attribute the latest earnings of FY24, FY25, and FY26 to the expanded equity base post-issue, then the asking price is at a Post-Issue P/E of around 42.93x, 22.00x, and 17.53x respectively. As per RHP, a comparison between listed peers shows that there are no strictly comparable listed companies in India operating in this exact business segment or size, making direct peer benchmarking inapplicable. On BRLM's front, Marwadi Chandarana Intermediaries Brokers Private Limited are associated with this IPO, and Marwadi Chandarana Intermediaries Brokers Private Limited has handled 11 IPOs in the last three fiscal years. (as on 25.07.26) As per financials, H. R. Hygiene Products Limited has shown excellent accounting revenue growth but dismal cash flow conversion, RoNW is 26.91% and the Post-Issue P/E is 42.93x, 22.00x, and 17.53x respectively as per FY24, FY25, and FY26 earnings. So the issue looks aggressively priced when adjusting for poor earnings quality and toxic receivables. The company is a growing FMCG manufacturer operating in the personal care space offering products starting from economy sanitary napkins (Femiss) to infant and adult diapers (Bloom Baby and ElderFit). So, we give a AVOID rating for this IPO. Readers must consult a qualified financial advisor prior to making any actual investment decisions.
✍️ Post a Comment